-
CXCR4/CD184 (EP394)
CXCR4/CD184 (EP394)
- 中文名称：
- CXCR4/CD184 (EP394)
- 英文名称：
- CXCR4/CD184 (EP394)
- 品牌：
- AAA Biotech
- 品牌介绍：
- AAA Biotech专注于为全球生命科学研究提供高品质的蛋白质研究工具，核心产品包括经严格验证的抗体、重组蛋白及ELISA试剂盒。
- 货号：
- AAA59364
- 规格：
- 3 mL (RTU)|0.1 mL (Concentrate)|7 mL (RTU)|0.5 mL (Concentrate)|15 mL (RTU)
- 保存建议：
- Store at 2-8 degree C (Control Slides: Store at 20-25 degree C)
- 货期：
- 6-8周
- 来源宿主：
- Rabbit
- 反应种属：
- Human, Mouse
- 免责声明：
- *本产品仅供科研实验使用，不得用于临床诊断。*
- 其他：
克隆性:Monoclonal
同型:IgG
克隆号:[EP394]
特异性:N/A
纯度:N/A
形式：Paraffin, Frozen
CXCR4/CD184 is a rabbit monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH7.5, containing BSA and sodium azide as a preservative.
浓度：N/A
- 说明书：
Chemokine Receptor 4 (CXCR4, also CD184 or Fusin) is a homeostatic chemokine. Its major function is to regulate hematopoietic cell trafficking and secondary lymphoid tissue architecture. CXCR4 is widely expressed on Hematopoietic cells, including CD34+ HSC, T Lymphocytes, B Lymphocytes, Monocytes, Macrophages, Neutrophils, and Eosinophils, as well as organs including Brain, Heart, Colon, and Kidney, and Endothelial cells, Epithelial cells, and Smooth Muscle progenitors.
With roles in cell homing and tissue repair, CXCR4 is involved in cancer cell physiology, survival, and metastasis in >20 cancer types. CXCR4 induces and recruits stem cells and promotes angiogenesis in tumors, and responds to CXCL12 expression to promote metastasis in cancers of the Bone, Brain, Breast, Lung, Liver, Kidney, and other tissues. The SDF-1/CXCR4 axis plays a crucial role in engraftment, where CXCR4 antibody expression is correlated with inflammation and graft rejection. The most studied role for CXCL12 chemokine and its receptor CXCR4 in Breast Cancer pathogenesis is the metastasis event, although several reports have demonstrated its involvement in other processes, such as angiogenesis and tumor growth. It has been found that CXCR4 is required for Breast Cancer cell migration to other sites such as Lung, Bone, and Lymph nodes, which express high levels of CXCL12 chemokine. Therefore, CXCR4 antibody is being considered a prognostic marker in Breast Cancer.
